BRIEF published on 07/25/2025 at 13:47, 4 months 10 days ago Arkema: Declaration of Voting Rights as of June 30, 2025 Voting Rights Actions Regulation ARKEMA June 2025
BRIEF published on 07/22/2025 at 10:29, 4 months 13 days ago Arkema Conducts Share Buyback Transactions Share Buyback Financial Transactions Stock Market Regulations ARKEMA
PRESS RELEASE published on 07/22/2025 at 10:24, 4 months 13 days ago Inside Information / Other news releases Arkema discloses trading in own shares from 14 to 17 July 2025, complying with regulations. Learn more on Arkema's website Investor Relations Trading Compliance Own Shares ARKEMA
BRIEF published on 07/15/2025 at 09:51, 4 months 20 days ago Arkema Announces Share Buyback Transactions Share Buyback Financial Regulation ARKEMA EU Compliance July 2025
PRESS RELEASE published on 07/15/2025 at 09:46, 4 months 20 days ago Inside Information / Other news releases Arkema discloses trading in own shares from 07 July to 11 July 2025, in compliance with regulations. Total daily volume acquired: 21,655 shares at a weighted average price of 63.0802. More info on Arkema's website Share Buyback Trading Compliance Own Shares ARKEMA
BRIEF published on 07/09/2025 at 08:35, 4 months 26 days ago Arkema Invests in Transparent Polyamide in Singapore Sustainability Investment ARKEMA Polyamide Production Singapore Manufacturing
BRIEF published on 07/08/2025 at 11:37, 4 months 27 days ago Transactions on Arkema's own shares in early July 2025 Own Shares EU Regulation ARKEMA Stock Market Transactions July 2025
PRESS RELEASE published on 07/08/2025 at 11:32, 4 months 27 days ago Inside Information / Other news releases Arkema discloses trading in own shares from 01 to 04 July 2025 in compliance with regulations. Total volume of 16,659 shares acquired at a weighted average price of 62.9889 Acquisition Shares Trading Compliance ARKEMA
BRIEF published on 07/02/2025 at 16:03, 5 months 2 days ago 2025 Half-Year Review of Arkema's Liquidity Contract Liquidity Contract NATIXIS ODDO BHF Financial Transactions ARKEMA Semester 2025
PRESS RELEASE published on 07/02/2025 at 15:58, 5 months 2 days ago Inside Information / Other news releases Arkema's liquidity contract with Natixis ODDO BHF for the first half of 2025 reveals transactions of 89,273 shares worth €8.4M Liquidity Contract NATIXIS ODDO BHF Transactions Shares ARKEMA
Published on 12/05/2025 at 02:35, 3 hours 53 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 28 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 23 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 28 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 13 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 17 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 28 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 27 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
